Revellex 100 Mg 100mg Injection
PDF Leaflet Revision Date: 2 September 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis, Crohn's disease, and ulcerative colitis.
Dosage (summary)
Rheumatoid arthritis: 3 mg/kg IV at weeks 0, 2, 6, then every 8 weeks. Other indications: 5 mg/kg IV at weeks 0, 2, 6, then every 6-8 weeks.
Onset of Action / Duration
Onset: 12 weeks, Duration: Varies by indication.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Use contraception during treatment; low risk of major malformations in pregnancy; caution in breastfeeding.
Key Drug Interactions
- Anakinra
- Abatacept
- Live vaccines
Contraindications
- Hypersensitivity to infliximab
- Active infections
- Moderate to severe heart failure
Common side effects
- Upper respiratory tract infection
- Infusion reactions
- Headache
- Abdominal pain
Counselling Points
- Monitor for infections
- Avoid live vaccines
- Report any infusion reactions immediately
Serious warnings
- Risk of serious infections
- Risk of malignancies
- Heart failure exacerbation
Important Disclaimer
The Revellex 100 Mg 100mg Injection professional information leaflet below is the property of Janssen Pharmaceutica and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
